FR2747121B1 - Nouveaux derives de 2,3-benzodiazepine - Google Patents

Nouveaux derives de 2,3-benzodiazepine

Info

Publication number
FR2747121B1
FR2747121B1 FR9704063A FR9704063A FR2747121B1 FR 2747121 B1 FR2747121 B1 FR 2747121B1 FR 9704063 A FR9704063 A FR 9704063A FR 9704063 A FR9704063 A FR 9704063A FR 2747121 B1 FR2747121 B1 FR 2747121B1
Authority
FR
France
Prior art keywords
novel
benzodiazepine derivatives
benzodiazepine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9704063A
Other languages
English (en)
Other versions
FR2747121A1 (fr
Inventor
Istvan Ling
Gizella Abraham
Pal Berzsenyi
Istvan Tarnawa
Sandor Solyom
Ferenc Andrasi
Tamas Hamori
Emese Csuzdi
Katalin Horvath
Melinda Gal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of FR2747121A1 publication Critical patent/FR2747121A1/fr
Application granted granted Critical
Publication of FR2747121B1 publication Critical patent/FR2747121B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR9704063A 1996-04-04 1997-04-03 Nouveaux derives de 2,3-benzodiazepine Expired - Fee Related FR2747121B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9600871A HU9600871D0 (en) 1996-04-04 1996-04-04 New 2,3-benzodiazepine derivatives
US08/832,777 US5807851A (en) 1996-04-04 1997-04-04 2,3-Benzodiazepine Derivatives as non-competitive AMPA

Publications (2)

Publication Number Publication Date
FR2747121A1 FR2747121A1 (fr) 1997-10-10
FR2747121B1 true FR2747121B1 (fr) 1998-08-21

Family

ID=89993863

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9704063A Expired - Fee Related FR2747121B1 (fr) 1996-04-04 1997-04-03 Nouveaux derives de 2,3-benzodiazepine

Country Status (13)

Country Link
US (1) US5807851A (fr)
EP (1) EP0802195B1 (fr)
JP (1) JP3131767B2 (fr)
AU (1) AU1636297A (fr)
CZ (1) CZ291520B6 (fr)
EA (1) EA000471B1 (fr)
FR (1) FR2747121B1 (fr)
GB (1) GB2311779B (fr)
GR (1) GR1002883B (fr)
HR (1) HRP970186B1 (fr)
HU (1) HU9600871D0 (fr)
PL (1) PL319270A1 (fr)
SK (1) SK282258B6 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19604919A1 (de) * 1996-02-01 1997-08-07 Schering Ag Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
EP1300396B1 (fr) 2000-06-12 2009-01-14 Eisai R&D Management Co., Ltd. Composes 1,2-dihydropyridine, leur procede de preparation et leur utilisation
HU225100B1 (hu) * 2000-12-21 2006-06-28 Egyt Gyogyszervegyeszeti Gyar 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk
GB0129260D0 (en) 2001-12-06 2002-01-23 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses
US20040152694A1 (en) * 2003-02-04 2004-08-05 Istvan Kurucz Methods and compositions for treating inflammatory disorders of the airways
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
HUP0302449A3 (en) * 2003-08-04 2005-06-28 Egis Gyogyszergyar Nyilvanosan 8-chloro-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for producing them
MY148809A (en) 2004-07-06 2013-05-31 Eisai R&D Man Co Ltd Crystals of 1,2-dihydropyridine compound and their production process
EA016087B1 (ru) * 2005-12-30 2012-02-28 Эгиш Дьёдьсердьяр Ньильваношан Мюкёдё Ресвеньтаршашаг Оптические изомеры дигидро-2,3-бензодиазепинов и их стереоселективный синтез
EP2338492A1 (fr) 2009-12-24 2011-06-29 Universidad del Pais Vasco Procédés et compositions pour le traitement de la maladie d'Alzheimer
US9890147B2 (en) * 2012-08-16 2018-02-13 Bayer Pharma Aktiengesellshaft 2,3-benzodiazepines
WO2016062688A1 (fr) * 2014-10-23 2016-04-28 Bayer Pharma Aktiengesellschaft Dérivés de 1-phényl-4,5-dihydro-3h-2,3-benzodiazépines
CN113226286A (zh) 2018-12-14 2021-08-06 卫材R&D管理有限公司 1,2-二氢吡啶化合物的水基药物制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179018B (en) * 1978-10-19 1982-08-28 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivatives
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU208429B (en) * 1991-05-03 1993-10-28 Gyogyszerkutato Intezet Process for producing 1-/3-chloro-phenyl/-4-methyl-7,8-dimethoxy-5h-2,3-benzodiazepine of high purity

Also Published As

Publication number Publication date
GR1002883B (el) 1998-03-24
EA199700030A3 (ru) 1997-12-30
PL319270A1 (en) 1997-10-13
EA000471B1 (ru) 1999-08-26
SK282258B6 (sk) 2001-12-03
EP0802195A3 (fr) 1997-12-03
EA199700030A2 (ru) 1997-09-30
HRP970186B1 (en) 2002-06-30
JP3131767B2 (ja) 2001-02-05
EP0802195A2 (fr) 1997-10-22
US5807851A (en) 1998-09-15
GB2311779B (en) 1999-07-14
GB9706945D0 (en) 1997-05-21
HRP970186A2 (en) 1998-10-31
HU9600871D0 (en) 1996-05-28
EP0802195B1 (fr) 2003-11-19
CZ291520B6 (cs) 2003-03-12
GB2311779A (en) 1997-10-08
SK42397A3 (en) 1998-01-14
AU1636297A (en) 1997-10-09
CZ97897A3 (en) 1997-10-15
JPH1036356A (ja) 1998-02-10
FR2747121A1 (fr) 1997-10-10

Similar Documents

Publication Publication Date Title
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
PT901474E (pt) Derivados de aril-pirimidina.
MA26831A1 (fr) Derives de benzodiazepine."
DZ2169A1 (fr) Nouveaux dérivés de 19-nor-prégnéne.
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
PT922050E (pt) Derivados de 3-descladinose-2,3-anidroeritromicina
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
MA26503A1 (fr) Derives de 5'-desoxy-cytidine.
FR2747121B1 (fr) Nouveaux derives de 2,3-benzodiazepine
BR9709251A (pt) Derivados de 2,4-diaminopirimidina
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
MA23504A1 (fr) Derives de la 1,5 benzodiazepine
FR2727680B1 (fr) Nouveaux derives de 5-pyrrolyl-6-halogeno-2- pyridylmethylsufinylbenzimidazole
MA23563A1 (fr) Nouveaux derives dialkoxy - pyridinyle - benzimidazole
MA26440A1 (fr) Derives de n-benzylazolium
MA24410A1 (fr) Derives de 4-hydroxypiperidine
DE69622415D1 (de) 12H-Dibenzo[d,g][1,3]dioxocin Derivate
BR9701404A (pt) Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol
NO973624D0 (no) Vasokonstriktive substituerte 2,3-dihydro-1,4-dioksinopiperidiner
DK0810216T3 (da) Derivater af 10,11-dihydro-10-oxo-5H-dibenz/b/,f/azepin-5-carboxamid
NO962931D0 (no) N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat
MA24068A1 (fr) Nouveaux derives de 19-nor- pregnene
FR2722499B1 (fr) Nouveaux derives de 2-imidazoline-5-ones fongicides

Legal Events

Date Code Title Description
ST Notification of lapse